Search NASA⌕ Search

Engineering topics

S. Robin Elgart

Publications and source records attributed to S. Robin Elgart.

At least 19 records
All sourcesNASA NTRSDOE OSTI
NASA NTRS2023

Evidence Report: Risk of Ineffective or Toxic Medication During Long-Duration Exploration Spaceflight

The scope of this report is limited to evaluating drug stability with respect to spaceflight. The effects of spaceflight on drug pharmacokinetics (PK) or drug pharmacodynamics (PD) are not addressed in this report: these topics will be reviewed in future reports. This is the first report of the available evidence pertaining to the chemical and physical stability of drugs in the context of drug impurity, drug repackaging, and exposure to ionizing space radiation. Previous studies are discussed within this report and, where possible, the data are interpreted and contextualized with regards to drug stability.

John F. Reichard↗
NASA NTRSDate not supplied

Quantifying radiation quality for space relevant radiation types: Fitting excess risk models to outbred mice data

Accurately quantifying the differences in radiation quality between space and terrestrial environments is important for predicting health risks for astronauts.Recently, Edmundson et al. 2020[1] provided valuable new results from out-bred mice linking tumor induction and genetic background aer exposure to low and high-LET radiation. The goal of the current study is to more rigorously estimate a relative biological effectiveness (RBE) factor by leveraging the solid tumor data from Edmundson et al. 2020. Excess relative risk (ERR) models and excess absolute risk (EAR) models were fit using Poisson regression similar to the models that the Radiation Effects Research Foundation uses to fit atomic bomb survivor data. Linear ERR and EAR slopes were simulated usingBayesian analyses, and RBE values were calculated from the ratio of the heavy ion linear slope to the gamma linear slope using the full posterior distribution.

Lori J. Chappell↗
NASA NTRSDate not supplied

Space Radiation: It’s Everywhere We Want to Be

Characterize and facilitate the management of the human health outcomes associated with space radiation exposure to protect astronaut health and wellbeing to enable human spaceflight.

S. Robin Elgart↗
NASA NTRSDate not supplied

Quantifying radiation quality for space relevant radiation types: Fitting excess risk models to three combined HZE-irradiated mouse datasets

Radiation health risks are predominantly derived from low linear energy transfer (LET) terrestrial exposures; however, space radiation includes exposure to high-LET and high-charge, high-energy (HZE) particles. Accurately quantifying the differences in radiation quality between the space and terrestrial radiation environments is important for assessing and predicting health risks for astronauts. Weil et al. 2009 and 2014 used two different inbred mouse strains to study differences in hepatocellular carcinoma (HCC) tumorigenesis after exposures to low- and high- LET radiation. More recently, Edmundson et al. 2020 provided valuable new tumor data in outbred mice that were exposed to low- and high-LET radiation. The present study aims to rigorously investigate a relative biological effectiveness (RBE) factor by leveraging the HCC tumor data from Weil et al. 2009, Weil et al. 2014, and Edmundson et al. 2020. The three experiments were similarly designed, allowing the raw data to be combined into a pooled dataset to estimate excess relative risk (ERR) and excess absolute risk (EAR) models using Bayesian Poisson regression. These effect estimates from the pooled data provide greater power to calculate a data driven RBE. Extensive sensitivity analyses test the robustness of RBE estimates to various model assumptions. The following questions will be explored through the sensitivity analyses: • Is the shape of the dose response different for low-LET radiation and HZE radiation, indicating that RBE is a function of dose? • Does attained age modify the effect estimates differently for low-LET radiation and HZE radiation, indicating RBE is a function of attained age? • Are the effect estimates and RBE estimates different for inbred mouse strains and outbred mouse strains? • Do assumptions about differences in ERR models and EAR models change the estimated RBE? Additional studies would be needed to validate the findings from these exploratory analyses.

Lori J. Chappell↗
NASA NTRSDate not supplied

Quantifying radiation quality for space relevant radiation types: Fitting excess risk models to three combined HZE-irradiated mouse datasets

Radiation health risks are predominantly derived from low linear energy transfer (LET) terrestrial exposures; however, space radiation includes exposure to high-LET and high-charge, high-energy (HZE) particles. Accurately quantifying the differences in radiation quality between the space and terrestrial radiation environments is important for assessing and predicting health risks for astronauts. Weil et al. 2009 and 2014 used two different inbred mouse strains to study differences in hepatocellular carcinoma (HCC) tumorigenesis after exposures to low- and high- LET radiation[1-2]. More recently, Edmondson et al. 2020 provided valuable new tumor data in outbred mice that were exposed to low- and high-LET radiation[3]. The present study aims to rigorously investigate a relative biological effectiveness (RBE) factor by leveraging the HCC tumor data from the three datasets[1-3]. The three experiments were similarly designed, allowing the raw data to be combined into a pooled dataset to estimate excess relative risk (ERR) and excess absolute risk (EAR) models using Bayesian Poisson regression.

Lori J. Chappell↗
NASA NTRSDate not supplied

Space Health Impacts for the NASA Experience (SHINE): 2023 Space Radiation Didactic Curriculum

SHINE Training Program - Provide important information about the relevant scientific elements of the Human Research Program (HRP) Space Radiation is hopefully just the first to provide a curriculum - Targets graduate students to potential new investigators with an emphasis on early career investigators - Virtual program meant to improve inclusion

S. Robin Elgart↗
NASA NTRSDate not supplied

Summary of the virtual Space Radiation “2022 Biospecimen and Tissue Sharing Summit.”

The Space Radiation Element (SRE) of the Human Research Program (HRP) aims to establish a robust biospecimen and tissue sharing collection (BTSC) to improve sample collection, tracking, access, distribution, and usability to maximize scientific return with intention. Leveraging biospecimens and tissues from prior experiments helps HRP achieve its scientific goals to characterize and mitigate the human health impacts of spaceflight by maximizing resources. The project intends to expand on the National Aeronautics and Space Agency’s (NASA) current resources and institutional knowledge to provide ongoing modernization to improve the usability and access to the current biospecimen archive. SRE organized and held a three-day virtual workshop September 13-15, 2022, to engage with the research community with the following goals: - Share information about: - Space Radiation’s current Biospecimen and Tissue Sharing Project; - Software implementation to track biospecimens; - NASA’s current tissue sharing capabilities and projects; and - Collect community feedback on how to develop, streamline, and optimize accessible and usable processes. The first two days featured speakers internal and external to NASA who presented on current resources, best practices, lessons learned, and researcher perspectives. On the third day, a set of key questions were presented, and participants were invited to discuss and provide input.

Shelita Hall Augustus↗
NASA NTRSDate not supplied

Overview of the Inaugural Space Health Impacts for the NASA Experience (SHINE) Training Program – Virtual Space Radiation Curriculum

The Space Radiation Element part of NASA Human Research Program initiated a virtual, annual space radiation curriculum. The SHINE space radiation curriculum aims to educate participants not only in the scientific aspects of space radiation but also in the agency’s risk management strategies. SHINE combines weekly seminars by speakers from NASA, other government agencies, academia, and industry, with networking sessions designed to foster collaboration between participants and interactions with NASA scientists. A total of 59 applications were received from which 25 participants were selected. The 25 participants, with citizenship from a total of 8 countries, are composed of 5 graduate students, 4 postdocs, 11 scientists and 5 professors/medical doctors. Participants have a wide range of expertise including molecular and cellular biology, microbiology, botany, physiology, engineering, physics, aerospace medicine, planetary science, biostatistics, and modeling. The inaugural course ran weekly from February 2023 to August 2023 and was comprised of lectures, less formal coffee hours and office hours. The topics covered ranged from space environments to health effects to granting opportunities. The second annual SHINE training program is scheduled from February to August 2024. In addition, a separate competitive practicum session, to allow participants to gain hands-on radiation experience, will be held Fall 2024 at the NASA Space Radiation Laboratory (NSRL).

Janice A. Zawask↗
NASA NTRSDate not supplied

Conclusions of a Mini Technical Interchange Meeting on Mechanisms and Pathways Common Between Adverse Health Outcomes from Exposures to Space Radiation

To enable deep space exploration and sustained human presence in space, the NASA Human Research Program’s (HRP) Space Radiation Element (SRE) funds research to characterize and mitigate adverse health outcomes from exposure to space radiation that include risks of carcinogenesis, cardiovascular disease (CVD) and central nervous system (CNS) decrements. Over the past decade, a growing body of compelling experimental evidence suggests shared mechanisms and pathophysiological processes for CVD, neurodegenerative effects, and cancer development and progression, which are traditionally managed as separate disease processes. Additionally, epidemiological studies have identified cross-sectional and longitudinal associations between some specific types of cancer and CVD, and accumulating evidence indicates that the pathogenesis of neurodegenerative diseases such as Alzheimer’s disease may overlap with CVD and cancer pathogenesis. Identifying the mechanisms and pathways common to these important health decrements will not only accelerate development of effective countermeasures and improve management of spaceflight-induced risk, it will also help to develop new treatment strategies for patients on Earth. To identify common pathways and mechanisms of disease induction and progression from current SR-funded studies and to inform future work and solicitations, the SRE organizes themed sessions at annual HRP Investigators’ Workshops (IWS). These technical interchange meetings (TIMs) provide a venue for the scientific community to present ongoing work and engage in open discussion on results, limitations of current approaches, and incorporation of novel experimental strategies, model systems, and other innovative techniques. Here a summary and lessons learned from the SRE-sponsored mini-TIM titled “mechanisms and pathways common between adverse health outcomes” held at HRP IWS 2023 will be communicated. The 90-min TIM had 30-min dedicated to discussing and developing potential collaboration and tissue sharing opportunities among investigators. The SRE facilitated the discussion using a set of pressing questions and gaps in knowledge that need to be addressed by the scientific community. This poster presents the outcomes of the session along with proposed future workshops and other SRE initiatives.

Janapriya Saha↗
NASA NTRSDate not supplied

Biological Space Radiation Countermeasures to Enable Long Duration Exploration Missions

NASA’s career radiation limit for astronauts is 600 mSv. Currently planned missions beyond low Earth orbit (LEO) will expose crew to at least double that amount of radiation (for Mars missions). Therefore, to enable long duration exploration, countermeasures need to be deployed to reduce the long-term health outcomes of space radiation exposure. Limitations to the ability of spacecraft to shield against the high energy charged particles of the space radiation environment necessitate alternative methods to reduce overall space radiation risk for carcinogenesis. Recent successes in the arenas of Acute Radiation Syndrome (ARS) and clinical radiotherapy have demonstrated the efficacy of compound-based/biologicals in reducing the detrimental long term health outcomes associated with space radiation exposure. In recent years, the Space Radiation Element has funded the investigation of several such compounds including Avasopasem Manganese, CDDO-Me, Metformin, and γ-tocotrienol. The demonstrated efficacy of these compounds in reducing carcinogenesis, central nervous system, and cardiovascular disease risks demonstrate the need for, and potential benefit of, a robust countermeasure identification and development program with an initial starting suite of compounds available to validate others. The authors would also like to present highlights of a recent Space Radiation Element sponsored issue of Life Sciences in Space Research entitled “Breaking the Limit” on this specific topic.

Space Radiation↗